Patent details

EP1040094 Title: SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS

Basic Information

Publication number:
EP1040094
PCT Application Number:
PCT/US/1998/026871
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP989660030
PCT Publication Number:
WO/1999/033781
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS
French Title of Invention:
COMPOSES DES CYCLOPENTANE ET CYCLOPENTENE CONVENANT COMME INHIBITEURS DE NEURAMINIDASE
German Title of Invention:
SUBSTITUIERTE CYCLOPENTAN- UND CYCLOPENTEN-VERBINDUNGEN ALS NEURAMINIDASE-BLOCKER
SPC Number:
LUC00084

Dates

Filing date:
17/12/1998
Grant date:
18/03/2009
EP Publication Date:
18/03/2009
PCT Publication Date:
08/07/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/10/2000
EP B1 Publication Date:
18/03/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/12/2018
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/08/2018
 
 

Name:
BIOCRYST PHARMACEUTICALS, INC.
Address:
4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703, United States (US)

Inventor

1

Name:
BABU Yarlagadda, S.
Address:
United States (US)

2

Name:
MONTGOMERY John, A.
Address:
United States (US)

3

Name:
CHAND Pooran
Address:
United States (US)

Priority

1

Priority Number:
69956 P
Priority Date:
17/12/1997
Priority Country:
United States (US)

2

Priority Number:
85252 P
Priority Date:
13/05/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
C07C 69/74;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2017
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
29/08/2018 Request For Change 7
29/08/2018 Outgoing Correspondence 1